MMP9 and STAT1 are biomarkers of the change in immune infiltration after anti-tuberculosis therapy, and the immune status can identify patients with spinal tuberculosis
Authors:
Open Access
- 9 February 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 116, 109588
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Signaling pathway STAT1 is strongly activated by IFN-β in the pathogenesis of osteoporosisEuropean Journal of Medical Research, 2015
- Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosisThe Brazilian Journal of Infectious Diseases, 2014
- Alveolar macrophages: plasticity in a tissue-specific contextNature Reviews Immunology, 2014
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Spinal tuberculosisThe Lancet, 2011
- Spinal tuberculosis: A reviewThe Journal of Spinal Cord Medicine, 2011
- Genetically Determined Susceptibility to Tuberculosis in Mice Causally Involves Accelerated and Enhanced Recruitment of GranulocytesInfection and Immunity, 2006
- Inhibition of Neutrophil Apoptosis by TLR Agonists in Whole Blood: Involvement of the Phosphoinositide 3-Kinase/Akt and NF-κB Signaling Pathways, Leading to Increased Levels of Mcl-1, A1, and Phosphorylated BadThe Journal of Immunology, 2005
- STRING: a database of predicted functional associations between proteinsNucleic Acids Research, 2003
- Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)Critical Reviews in Biochemistry and Molecular Biology, 2002